{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:37:53Z","timestamp":1766180273397},"reference-count":32,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T00:00:00Z","timestamp":1261008000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>In low vaccination coverage regions (LVR) in The Netherlands people often reject participation in the National Immunization Programme for religious reasons. During a rubella epidemic in 2004\u20132005, 32 pregnant women were notified with rubella, and 11 babies were born with defects related to maternal infection. This study presents a cost-utility analysis of a screening and vaccination programme for rubella focusing on three scenarios: (1) screening non-vaccinated pregnant women in LVR; (2) screening all pregnant women in LVR; (3) screening all non-vaccinated pregnant women in The Netherlands (including pregnant first-generation non-Western immigrant women). Cost-utility was estimated over a 16-year period which included two rubella outbreaks. Observed complications from the 2004\u20132005 epidemic were used to estimate average cost savings and quality-adjusted life-years (QALY) gained. The programme would be cost-effective (\u20ac1100\/QALY gained) when assuming an acceptability of vaccination of 20% in women belonging to orthodox protestant risk groups.<\/jats:p>","DOI":"10.1017\/s0950268809991336","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T15:37:52Z","timestamp":1261064272000},"page":"1172-1184","source":"Crossref","is-referenced-by-count":11,"title":["A cost-utility analysis of antenatal screening to prevent congenital rubella syndrome"],"prefix":"10.1017","volume":"138","author":[{"given":"A. K.","family":"LUGN\u00c9R","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"MOLLEMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. L. M.","family":"RUIJS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J. M.","family":"HAHN\u00c9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,12,17]]},"reference":[{"key":"S0950268809991336_ref012","first-page":"137","article-title":"Seroprevalence of rubella in children and pregnant women seeking asylum [in Dutch]","volume":"12","author":"Knoppers","year":"2005","journal-title":"Infectieziektenbulletin"},{"key":"S0950268809991336_ref008","unstructured":"8. Buiker M , Schout C . Antibodies against rubella in pregnant women from different ethnic groups in Amsterdam, 1985\u20131986: a study in six midwifery practices [in Dutch]. Rapport van Gemeentelijke Geneeskundige en Gezondheidsdienst Amsterdam, 1987, 28 pp."},{"key":"S0950268809991336_ref014","unstructured":"14. Van der Zwan CW , Study of immune status of mumps, measles, rubella, poliomyelitis, diphtheria and tetanus in immigrants in \u2019s-Hertogenbosch in March 1990 until March 1992 [in Dutch]. RIVM Report 213676002, 1995, 17 pp."},{"key":"S0950268809991336_ref007","first-page":"306","article-title":"Rubella and congenital rubella syndrome: global update","volume":"14","author":"Robertson","year":"2003","journal-title":"Revista Panamericana de Salud P\u00fablica\/Pan American Journal of Public Health"},{"key":"S0950268809991336_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15897-2"},{"key":"S0950268809991336_ref013","first-page":"142","article-title":"Rubella immune status in immigrant pregnant women in Zaandam [in Dutch]","volume":"12","author":"Tjon","year":"2001","journal-title":"Infectieziektenbulletin"},{"key":"S0950268809991336_ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.24.18901-en","article-title":"Mumps in a community with low vaccination coverage in the Netherlands","volume":"13","author":"Karagiannis","year":"2008","journal-title":"Eurosurveillance"},{"key":"S0950268809991336_ref003","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3201\/eid0707.017743","article-title":"Measles outbreak in a community with very low vaccine coverage, the Netherlands","volume":"7","author":"Hof","year":"2001","journal-title":"Emerging Infectious Diseases"},{"key":"S0950268809991336_ref028","volume-title":"Preconception care: a good beginning [in Dutch]","year":"2007"},{"key":"S0950268809991336_ref001","unstructured":"1. Lier EA v , Immunization coverage National Immunization Programme in the Netherlands, 2006\u20132008 [in Dutch]. RIVM Report 210021007\/2008, Bilthoven, The Netherlands, 2008."},{"key":"S0950268809991336_ref004","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/INF.0b013e3181a3e2d5","article-title":"Rubella outbreak in the Netherlands, 2004\u20132005: high burden of congenital infection and spread to Canada","volume":"28","author":"Hanh\u00e9","year":"2009","journal-title":"Pediatric Infectious Disease Journal"},{"key":"S0950268809991336_ref016","first-page":"39","volume-title":"Rubella Viruses","author":"Best","year":"2007"},{"key":"S0950268809991336_ref031","unstructured":"31. Foundation for Pharmaceutical Statistics. (http\/\/:www.sfk.nl\/). Accessed 15 November 2006."},{"key":"S0950268809991336_ref022","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268808001982"},{"key":"S0950268809991336_ref023","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899002939"},{"key":"S0950268809991336_ref019","unstructured":"19. CVZ. Guidelines for pharmacoeconomic research, updated version. Valid from 1 April 2006. Diemen; March, 2006."},{"key":"S0950268809991336_ref027","first-page":"151","article-title":"Survey of congenital rubella infections in the Netherlands in 1995\u20132002 [in Dutch]","volume":"15","author":"Hof","year":"2004","journal-title":"Infectieziektenbulletin"},{"key":"S0950268809991336_ref015","first-page":"149","article-title":"Rubella en zwangerschap: is rubella-screening nog wel zinvol?","volume":"15","author":"Elsacker","year":"2004","journal-title":"Infectieziektenbulletin"},{"key":"S0950268809991336_ref002","doi-asserted-by":"publisher","DOI":"10.1086\/324327"},{"key":"S0950268809991336_ref009","first-page":"1027","article-title":"Are you waiting for rubella: targeted screening for rubella remains necessary [in Dutch]","volume":"60","author":"Cornel","year":"2005","journal-title":"Medisch Contact"},{"key":"S0950268809991336_ref011","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899002939"},{"key":"S0950268809991336_ref025","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czl018"},{"key":"S0950268809991336_ref018","doi-asserted-by":"publisher","DOI":"10.2807\/esm.09.04.00462-en"},{"key":"S0950268809991336_ref020","unstructured":"20. Kiesraad. Election results database (www.verkiezingsuitslagen.nl). Accessed 15 November 2006."},{"key":"S0950268809991336_ref024","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2105\/AJPH.90.8.1241","article-title":"A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group","volume":"90","author":"Melse","year":"2000","journal-title":"American Journal of Public Health"},{"key":"S0950268809991336_ref026","unstructured":"26. RIVM. Costs of diseases (http:\/\/www.rivm.nl\/vtv\/object_document\/o5379n29501.html). Accessed 15 November 2006."},{"key":"S0950268809991336_ref029","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-4-1"},{"key":"S0950268809991336_ref030","unstructured":"30. RIVM. National Public Health Compass (http:\/\/www.rivm.nl\/vtv\/object_document\/o4237n16906.html). Accessed 15 November 2006."},{"key":"S0950268809991336_ref032","unstructured":"32. Oostenbrink JB , Guidelines for cost research. Methods and standard cost prices for economic evaluation in health care, updated version 2004 [in Dutch]."},{"key":"S0950268809991336_ref010","first-page":"149","article-title":"Rubella and pregnancy: is rubella-screening still meaningful? [in Dutch]","volume":"15","author":"Elsacker","year":"2004","journal-title":"Infectieziektenbulletin"},{"key":"S0950268809991336_ref017","doi-asserted-by":"publisher","DOI":"10.2807\/esm.09.04.00460-en"},{"key":"S0950268809991336_ref021","unstructured":"21. Statistics Netherlands (CBS). (http:\/\/www.cbs.nl\/nl-NL\/menu\/cijfers\/statline). Accessed 15 November 2006."}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268809991336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T06:58:30Z","timestamp":1634367510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268809991336\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,17]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0950268809991336"],"URL":"https:\/\/doi.org\/10.1017\/s0950268809991336","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,17]]}}}